Article info
Clinical science
Cumulative retention rate of adalimumab in patients with Behçet’s disease-related uveitis: a four-year follow-up study
- Correspondence to Claudia Fabiani, Department of Ophthalmology, Humanitas Clinical and Research Center, via Manzoni 56, 20089 Rozzano, Milan, Italy; claudia.fabiani{at}gmail.com and Dr Luca Cantarini, Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Auto inflammatory Diseases and Behçet’s Disease and Rheumatology-Ophthalmology Collaborative Uveitis Center, University of Siena, Viale Bracci 1, Siena, 53100, Italy; cantariniluca{at}hotmail.com
Citation
Cumulative retention rate of adalimumab in patients with Behçet’s disease-related uveitis: a four-year follow-up study
Publication history
- Received May 15, 2017
- Revised July 17, 2017
- Accepted August 2, 2017
- First published August 26, 2017.
Online issue publication
April 19, 2018
Article Versions
- Previous version (26 August 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.